Application of LARS Ligament in Bone Prosthesis Replacement

Condition(s) studied

Investigational drug(s) / intervention(s)

LARS ligament and bone prosthesis replacement was performed: To report the postoperative complications and limb function of patients who underwent LARS ligament and bone prosthesis replacement in Henan Cancer Hospital.

Study summary

This is a single-center, prospective, real-world observational study designed to enroll all patients eligible for enrollment. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.

Eligibility

Primary outcome measure(s)

• Postoperative complications — From surgery to 24 months after surgery
  Complications of patients undergoing LARS ligament and bone prosthesis replacement.
• Limb function — Patients were enrolled until 24 months after surgery
  Limb function was assessed using the Musculoskeletal Oncology Society (MSTS) scoring scale for seven items, namely movement, pain, stability, deformity, strength, functional activity, and emotional receptiveness. The highest possible score is 35, with 5 points allocated to each project.

Trial sites (1)

More Henan Cancer Hospital trials in China

Other trials for the same condition